G
George L. Mutter
Researcher at Brigham and Women's Hospital
Publications - 147
Citations - 11589
George L. Mutter is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Endometrial intraepithelial neoplasia & Endometrial cancer. The author has an hindex of 55, co-authored 145 publications receiving 10954 citations. Previous affiliations of George L. Mutter include NewYork–Presbyterian Hospital & Case Western Reserve University.
Papers
More filters
Journal ArticleDOI
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
Lesley Lomo,Marisa R. Nucci,Kenneth R. Lee,Ming-Chieh Lin,Michelle S. Hirsch,Christopher P. Crum,George L. Mutter +6 more
TL;DR: Because p53 is an important marker for endometrial adenocarcinoma outcome, and cannot be predicted in advance in indeterminate cases, p53 immunostaining should be employed in cases with observer disagreement in a binary system.
Journal ArticleDOI
Involution of PTEN-null endometrial glands with progestin therapy.
TL;DR: In this paper, the authors show that progestin-assisted removal of PTEN-null endometrial glands in pre-and post-progestin-treated endometria is associated with the removal of endometrioid endometric cancer.
Journal Article
Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias.
TL;DR: The finding of monoclonal hyperplasia and lichen sclerosis suggests that clonal expansion may evolve before the development of morphological atypia in these epithelia.
Journal ArticleDOI
Emergence, Involution, and Progression to Carcinoma of Mutant Clones in Normal Endometrial Tissues
TL;DR: The temporal dynamics of clonal emergence, persistence, and involution are sufficiently complex that in the individual patient, the presence of a latent precancer has an unknown contribution to long-term cancer risk.
Journal ArticleDOI
Control of streptozotocin diabetes in chinese hamsters by cultured mouse islet cells without immunosuppression: A preliminary report
TL;DR: Cultured pancreas islet cells inside 50K hollow fibers were implanted into adult Chinese hamsters made diabetic with streptozotocin, either as isografts (hamster → hamster) or xenografteds (mouse → hamsters) with return to normoglycemia.